John M. Evans - 25 Jun 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Executive Officer, Director
Signature
By: Christine Bellon, as Attorney-in-Fact
Issuer symbol
BEAM
Transactions as of
25 Jun 2021
Transactions value $
$0
Form type
4
Filing time
30 Jun 2021, 18:00:24 UTC
Previous filing
16 Jun 2021
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Small acquisition under Rule 16a-6 $0 +32 +0% $0.00 1.02M 25 Jun 2021 Direct F1
transaction BEAM Common Stock Small acquisition under Rule 16a-6 $0 +32 +0% $0.00 1.02M 28 Jun 2021 Direct F1
transaction BEAM Common Stock Other $0 +32 +0% $0.00 1.02M 29 Jun 2021 Direct F1
holding BEAM Common Stock 223K 25 Jun 2021 By John M. Evans, III 2018 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of BEAM common stock held by ARCH Venture Fund IX, L.P. to its partners for no consideration.